From Academic Research to Industry

From Academic Research to Industry

From Academic Research to Industry

Chair: Gil Granot-Mayer, CEO, Yeda R&D – Technology Transfer, Weizmann Institute of Science

Block 1 – Life Cycle of Technology Transfer – From Initial Disclosure to Success Story

12:00 Gil Granot-Mayer, CEO, YEDA; “Introduction”

12:00-12:35 Panel:  Looking at Both Sides of the Curtain with Technology Transfer – New Technology Transfer Practices, the Convergence of Digital Technology into the Pharma World, Commercializing Platforms, and Better Understanding of what is Driving TTO Policy
Moderator: Mr. Benjamin Soffer, CEO, T3
Tamar Raz, CEO. Hadasit
Sylvie Luria, CEO Sheba
Yaron Daniely, CEO, Yissum
Shlomo Nimrodi, CEO, Ramot
Netta Cohen, CEO, BGN Technologies
Gil Granot-Mayer, CEO, Yeda
Larry Loev, CEO, Ariel Scientific Innovations

12:35-13:00 Showcase of New Start-ups from Academia Part 1 of 3
Moderator: Larry Loev, CEO, Ariel Scientific Innovations
Yitshak Francis, Scientific Advisor, Qrons; Ariel University
Yoram Eshel, CEO, On-Sight; Weizmann Institute of Science
Prof. Fuad Fares, Founder, CanCuRX; Haifa University
Jessica Weiss, CEO, Lydus Medical; Clalit

13:00-13:55 Major Israeli Success Stories in Life Sciences – Fireside Chat with Professors who Championed Academic Innovation into Industry
Moderator: Shay Sela, VP, Business Development of Life Sciences, YEDA
Prof. Michel Revel, MD, PhD, Professor Emeritus, Weizmann Institute of Science and Chief Scientist, Kadimastem Ltd
Prof. Yechezkel “Chezy” Barenholz, Hebrew University of Jerusalem and Founder of Numerous Startups
Prof. Moussa B.H. Youdim, Prof. Emeritus at the Technion, Founder of Numerous Startups, and President & Chief Scientific Officer at Youdim Pharmaceuticals
Prof. Avigidor Scherz, Weizmann Institute of Science and Developed the technology behind Steba BioTech

14:00-15:30 Lunch Break

Block 2 – Creating the Environment for Successful Technology Transfer:

15:30-16:10 Funding and Performing Translational Research – Models in Taking Bench Side Research to Market. (Collaboration with the IIA; Horizon 2020; NIH; Spark (Stanford) programs)
Moderator: Gil Granot-Mayer, CEO, YEDA
Michael Salgaller, Supervisor, Invention Development and Marketing Unit (IDMU), Technology Transfer Center, National Cancer Institute, National Institutes of Health
Pasi Sorvisto, Director, SPARK Finland Program
Leah Klapper, Chief Technology Officer, FutuRx
Prof. Eli Hazum, Head, IDEA program at YEDA
Aviv Zeevi Balasiano, VP, Head of Division – Technology Infrastructure Israel Innovation Authority
Eyal Zimlichman, Deputy Director General, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center

16:10-16:30 Showcase of New Start-ups from Academia Part 2 of 3
Moderator: Larry Loev, CEO, Ariel Scientific Innovations
Nadav Peles, Co-Founder, Acting CEO, Ta Geza; Sheba
Prof. Noam Shomron, CSO, Variantyx; TAU
Tomer Behor, CEO, RenewSenses; Hebrew University

16:30-17:15 View of the Israeli Life Science Ecosystem – How do we Realize the Potential?
Moderator: Daphna Murvitz, Co-founder & CEO, 8400 Health Network
Zeev Zehavi, Vice President, Venture Investments JnJ
Prof. David Sidransky, MD, General Partner at the Israel Biotech Fund
Einat Zisman, Former CEO of FutuRx
Yuval Ofek, Founder & Chairman at DayTwo
Roni Mamluk, PhD, CEO at Ayala Pharmaceuticals
Itai Kela, Senior Director, Head of Healthcare and Biotechnology, Israel Innovation Authority

17:15-17:50 Showcase of New Start-ups from Academia Part 3 of 3
Moderator: Larry Love, CEO, Ariel Scientific Innovations
Daria Lemann-Blumenthal, CEO, Belkin Laser; Sheba
Hila Goldman Aslan, CEO, DiA Imaging Analysis; Ben Gurion University
Prof. Ayala Pollack, MD, Inventor & Medical Director, OphtimedRx; Clalit
Seth Salpeter, Co-Founder & CTO, CuResponse, Weizmann Institute of Science

17:40 Gil Granot-Mayer, CEO, YEDA; “Closing Remarks”

By | 2018-05-14T16:29:12+00:00 February 19th, 2018|Comments Off on
From Academic Research to Industry

About the Author: